SCHEMBL15212658

SCHEMBL15212658

CCCCC/C=C\CCCCCCCC/C=C/CCC(O)CCCC/C=C/CCCCCC

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR1 O14842 2/20 0.58
FFAR4 Q5NUL3 2/20 0.58
NFKB1 P19838 1/20 0.51
NFKB2 Q00653 1/20 0.51
RELA Q04206 1/20 0.51
FAAH O00519 4/20 0.50
TRPV1 Q8NER1 1/20 0.48
GPR84 Q9NQS5 3/20 0.47
MEN1 O00255 1/20 0.47
CYP3A4 P08684 1/20 0.47
KMT2A Q03164 1/20 0.47
GMNN O75496 1/20 0.47
USP2 O75604 1/20 0.47
LMNA P02545 1/20 0.47
CYP1A2 P05177 1/20 0.47
POLB P06746 1/20 0.47
MAPT P10636 1/20 0.47
CYP2C9 P11712 1/20 0.47
ALOX15 P16050 1/20 0.47
APEX1 P27695 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL811152 1.00 FFAR1 (0.58) FFAR1FFAR4NFKB1NFKB2RELA
SCHEMBL15212660 1.00 FFAR1 (0.58) FFAR1FFAR4NFKB1NFKB2RELA
SCHEMBL15212659 1.00 FFAR1 (0.58) FFAR1FFAR4NFKB1NFKB2RELA
SCHEMBL811479 1.00 FFAR1 (0.58) FFAR1FFAR4NFKB1NFKB2RELA
SCHEMBL7204570 1.00 FFAR1 (0.58) FFAR1FFAR4NFKB1NFKB2RELA
SCHEMBL25362576 1.00 FFAR1 (0.58) FFAR1FFAR4NFKB1NFKB2RELA
SCHEMBL811478 1.00 FFAR1 (0.58) FFAR1FFAR4NFKB1NFKB2RELA
SCHEMBL811153 1.00 FFAR1 (0.58) FFAR1FFAR4NFKB1NFKB2RELA
SCHEMBL15211655 1.00 FFAR1 (0.58) FFAR1FFAR4NFKB1NFKB2RELA
SCHEMBL31556046 1.00 FFAR1 (0.58) FFAR1FFAR4NFKB1NFKB2RELA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2817287-A1 TRIALKYL CATIONIC LIPIDS AND METHODS OF USE THEREOF Protiva Biotherapeutics Inc. (CA) 2014-12-31 EP disclosed
WO-2013126803-A1 TRIALKYL CATIONIC LIPIDS AND METHODS OF USE THEREOF PROTIVA BIOTHERAPEUTICS INC. (CA) 2013-08-29 WO disclosed